These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

374 related items for PubMed ID: 21224849

  • 21. Enhanced Expression of Integrin αvβ3 Induced by TGF-β Is Required for the Enhancing Effect of Fibroblast Growth Factor 1 (FGF1) in TGF-β-Induced Epithelial-Mesenchymal Transition (EMT) in Mammary Epithelial Cells.
    Mori S, Kodaira M, Ito A, Okazaki M, Kawaguchi N, Hamada Y, Takada Y, Matsuura N.
    PLoS One; 2015; 10(9):e0137486. PubMed ID: 26334633
    [Abstract] [Full Text] [Related]

  • 22. TGF-β-induced epithelial-to-mesenchymal transition proceeds through stepwise activation of multiple feedback loops.
    Zhang J, Tian XJ, Zhang H, Teng Y, Li R, Bai F, Elankumaran S, Xing J.
    Sci Signal; 2014 Sep 30; 7(345):ra91. PubMed ID: 25270257
    [Abstract] [Full Text] [Related]

  • 23. TGF-β1 and FGF2 stimulate the epithelial-mesenchymal transition of HERS cells through a MEK-dependent mechanism.
    Chen J, Chen G, Yan Z, Guo Y, Yu M, Feng L, Jiang Z, Guo W, Tian W.
    J Cell Physiol; 2014 Nov 30; 229(11):1647-59. PubMed ID: 24610459
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Vasohibin-2 is required for epithelial-mesenchymal transition of ovarian cancer cells by modulating transforming growth factor-β signaling.
    Norita R, Suzuki Y, Furutani Y, Takahashi K, Yoshimatsu Y, Podyma-Inoue KA, Watabe T, Sato Y.
    Cancer Sci; 2017 Mar 30; 108(3):419-426. PubMed ID: 28064471
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. ETS1 induces transforming growth factor β signaling and promotes epithelial-to-mesenchymal transition in prostate cancer cells.
    Rodgers JJ, McClure R, Epis MR, Cohen RJ, Leedman PJ, Harvey JM, Australian Prostate Cancer BioResourceAustralian Prostate Cancer BioResource (APCB), Brisbane, Queensland, Australia., Thomas MA, Bentel JM.
    J Cell Biochem; 2019 Jan 30; 120(1):848-860. PubMed ID: 30161276
    [Abstract] [Full Text] [Related]

  • 30. Regulation of myofibroblast differentiation by miR-424 during epithelial-to-mesenchymal transition.
    Xiao X, Huang C, Zhao C, Gou X, Senavirathna LK, Hinsdale M, Lloyd P, Liu L.
    Arch Biochem Biophys; 2015 Jan 15; 566():49-57. PubMed ID: 25524739
    [Abstract] [Full Text] [Related]

  • 31. LncRNA-ATB promotes trastuzumab resistance and invasion-metastasis cascade in breast cancer.
    Shi SJ, Wang LJ, Yu B, Li YH, Jin Y, Bai XZ.
    Oncotarget; 2015 May 10; 6(13):11652-63. PubMed ID: 25871474
    [Abstract] [Full Text] [Related]

  • 32. Role of basic fibroblast growth factor-2 in epithelial-mesenchymal transformation.
    Strutz F, Zeisberg M, Ziyadeh FN, Yang CQ, Kalluri R, Müller GA, Neilson EG.
    Kidney Int; 2002 May 10; 61(5):1714-28. PubMed ID: 11967021
    [Abstract] [Full Text] [Related]

  • 33. Ets1 and ESE1 reciprocally regulate expression of ZEB1/ZEB2, dependent on ERK1/2 activity, in breast cancer cells.
    Sinh ND, Endo K, Miyazawa K, Saitoh M.
    Cancer Sci; 2017 May 10; 108(5):952-960. PubMed ID: 28247944
    [Abstract] [Full Text] [Related]

  • 34. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1.
    Gregory PA, Bert AG, Paterson EL, Barry SC, Tsykin A, Farshid G, Vadas MA, Khew-Goodall Y, Goodall GJ.
    Nat Cell Biol; 2008 May 10; 10(5):593-601. PubMed ID: 18376396
    [Abstract] [Full Text] [Related]

  • 35. Regulation of fibroblast growth factor 2 and fibroblast growth factor receptors by transforming growth factor beta in human osteoblastic MG-63 cells.
    Sobue T, Gravely T, Hand A, Min YK, Pilbeam C, Raisz LG, Zhang X, Larocca D, Florkiewicz R, Hurley MM.
    J Bone Miner Res; 2002 Mar 10; 17(3):502-12. PubMed ID: 11874241
    [Abstract] [Full Text] [Related]

  • 36. Tumor-promoting functions of transforming growth factor-β in progression of cancer.
    Miyazono K, Ehata S, Koinuma D.
    Ups J Med Sci; 2012 May 10; 117(2):143-52. PubMed ID: 22111550
    [Abstract] [Full Text] [Related]

  • 37. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
    Ji Q, Liu X, Han Z, Zhou L, Sui H, Yan L, Jiang H, Ren J, Cai J, Li Q.
    BMC Cancer; 2015 Mar 05; 15():97. PubMed ID: 25884904
    [Abstract] [Full Text] [Related]

  • 38. The ubiquitin ligase Siah is a novel regulator of Zeb1 in breast cancer.
    Chen A, Wong CS, Liu MC, House CM, Sceneay J, Bowtell DD, Thompson EW, Möller A.
    Oncotarget; 2015 Jan 20; 6(2):862-73. PubMed ID: 25528765
    [Abstract] [Full Text] [Related]

  • 39. Suppression of AGR2 in a TGF-β-induced Smad regulatory pathway mediates epithelial-mesenchymal transition.
    Sommerova L, Ondrouskova E, Vojtesek B, Hrstka R.
    BMC Cancer; 2017 Aug 15; 17(1):546. PubMed ID: 28810836
    [Abstract] [Full Text] [Related]

  • 40. ZEB1 drives epithelial-to-mesenchymal transition in lung cancer.
    Larsen JE, Nathan V, Osborne JK, Farrow RK, Deb D, Sullivan JP, Dospoy PD, Augustyn A, Hight SK, Sato M, Girard L, Behrens C, Wistuba II, Gazdar AF, Hayward NK, Minna JD.
    J Clin Invest; 2016 Sep 01; 126(9):3219-35. PubMed ID: 27500490
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.